Cargando…
FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918301/ https://www.ncbi.nlm.nih.gov/pubmed/33681647 http://dx.doi.org/10.1002/epi4.12475 |
| _version_ | 1783657891557801984 |
|---|---|
| author | French, Jacqueline A. Perucca, Emilio Sander, Josemir W. Bergfeldt, Lennart Baulac, Michel Auerbach, David S. Keezer, Mark Thijs, Roland D. Devinsky, Orrin Vossler, David G. Welty, Timothy E. |
| author_facet | French, Jacqueline A. Perucca, Emilio Sander, Josemir W. Bergfeldt, Lennart Baulac, Michel Auerbach, David S. Keezer, Mark Thijs, Roland D. Devinsky, Orrin Vossler, David G. Welty, Timothy E. |
| author_sort | French, Jacqueline A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7918301 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79183012021-03-05 FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force French, Jacqueline A. Perucca, Emilio Sander, Josemir W. Bergfeldt, Lennart Baulac, Michel Auerbach, David S. Keezer, Mark Thijs, Roland D. Devinsky, Orrin Vossler, David G. Welty, Timothy E. Epilepsia Open Invited Commentary John Wiley and Sons Inc. 2021-02-25 /pmc/articles/PMC7918301/ /pubmed/33681647 http://dx.doi.org/10.1002/epi4.12475 Text en © 2021 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Invited Commentary French, Jacqueline A. Perucca, Emilio Sander, Josemir W. Bergfeldt, Lennart Baulac, Michel Auerbach, David S. Keezer, Mark Thijs, Roland D. Devinsky, Orrin Vossler, David G. Welty, Timothy E. FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force |
| title | FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force |
| title_full | FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force |
| title_fullStr | FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force |
| title_full_unstemmed | FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force |
| title_short | FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force |
| title_sort | fda safety warning on the cardiac effects of lamotrigine: an advisory from the ad hoc ilae/aes task force |
| topic | Invited Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918301/ https://www.ncbi.nlm.nih.gov/pubmed/33681647 http://dx.doi.org/10.1002/epi4.12475 |
| work_keys_str_mv | AT frenchjacquelinea fdasafetywarningonthecardiaceffectsoflamotrigineanadvisoryfromtheadhocilaeaestaskforce AT peruccaemilio fdasafetywarningonthecardiaceffectsoflamotrigineanadvisoryfromtheadhocilaeaestaskforce AT sanderjosemirw fdasafetywarningonthecardiaceffectsoflamotrigineanadvisoryfromtheadhocilaeaestaskforce AT bergfeldtlennart fdasafetywarningonthecardiaceffectsoflamotrigineanadvisoryfromtheadhocilaeaestaskforce AT baulacmichel fdasafetywarningonthecardiaceffectsoflamotrigineanadvisoryfromtheadhocilaeaestaskforce AT auerbachdavids fdasafetywarningonthecardiaceffectsoflamotrigineanadvisoryfromtheadhocilaeaestaskforce AT keezermark fdasafetywarningonthecardiaceffectsoflamotrigineanadvisoryfromtheadhocilaeaestaskforce AT thijsrolandd fdasafetywarningonthecardiaceffectsoflamotrigineanadvisoryfromtheadhocilaeaestaskforce AT devinskyorrin fdasafetywarningonthecardiaceffectsoflamotrigineanadvisoryfromtheadhocilaeaestaskforce AT vosslerdavidg fdasafetywarningonthecardiaceffectsoflamotrigineanadvisoryfromtheadhocilaeaestaskforce AT weltytimothye fdasafetywarningonthecardiaceffectsoflamotrigineanadvisoryfromtheadhocilaeaestaskforce |